Cite
HARVARD Citation
Ostrowska, B. et al. (2021). Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation. Leukemia & lymphoma. 62 (12), pp. 3031-3034. [Online].